Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Other Working Capital Changes (2017 - 2025)

Historic Other Working Capital Changes for Protagonist Therapeutics (PTGX) over the last 9 years, with Q3 2025 value amounting to -$3.1 million.

  • Protagonist Therapeutics' Other Working Capital Changes rose 3422.46% to -$3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.2 million, marking a year-over-year decrease of 15333.02%. This contributed to the annual value of $30.6 million for FY2024, which is 184369.65% up from last year.
  • Per Protagonist Therapeutics' latest filing, its Other Working Capital Changes stood at -$3.1 million for Q3 2025, which was up 3422.46% from -$5.0 million recorded in Q2 2025.
  • In the past 5 years, Protagonist Therapeutics' Other Working Capital Changes ranged from a high of $45.0 million in Q1 2024 and a low of -$8.7 million during Q1 2021
  • Over the past 5 years, Protagonist Therapeutics' median Other Working Capital Changes value was -$1.8 million (recorded in 2022), while the average stood at -$77500.0.
  • The largest annual percentage gain for Protagonist Therapeutics' Other Working Capital Changes in the last 5 years was 582388.82% (2024), contrasted with its biggest fall of 319707.6% (2024).
  • Protagonist Therapeutics' Other Working Capital Changes (Quarter) stood at -$640000.0 in 2021, then plummeted by 236.41% to -$2.2 million in 2022, then skyrocketed by 92.06% to -$171000.0 in 2023, then plummeted by 3197.08% to -$5.6 million in 2024, then soared by 45.46% to -$3.1 million in 2025.
  • Its Other Working Capital Changes stands at -$3.1 million for Q3 2025, versus -$5.0 million for Q2 2025 and -$5.5 million for Q1 2025.